Archived Monthly Oncology Tumor Boards: A Multidisciplinary Approach to Individualized Patient Care - Gastric Cancer
Clinicians must consider disease stage, histology, biomarker expression and patient performance status to make decisions regarding optimal care. In addition, clinicians should regularly evaluate recent clinical trial data to make informed decisions on the most appropriate treatment plan, particularly as new targeted therapies become available.
Category
  • Gastric/Esophageal Cancer
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • CCM clock hours
  • Participation
Archived Monthly Oncology Tumor Boards: A Multidisciplinary Approach to Individualized Patient Care - Melanoma
Since immune checkpoint inhibitors and BRAF targeted therapies are now available, there are many patients with advanced melanoma who are surviving multiple lines of treatment, so the complexity of cases is increasing.
Category
  • Melanoma
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • CCM clock hours
  • Participation
Archived Monthly Oncology Tumor Boards: A Multidisciplinary Approach to Individualized Patient Care - Central Nervous System Cancers
Histopathologic and molecular characterization of high-grade gliomas should now be standard practice, as specific markers used to define molecular subgroups among some anaplastic gliomas have been shown to have prognostic value. However, there are currently no targeted agents that have shown efficacy in the treatment of glioblastoma. The differential benefit from concurrent versus adjuvant temozolomide in patients with anaplastic gliomas continues to be unclear.
Category
  • CNS Cancers
  • Glioma
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • CCM clock hours
  • Participation
Bonanza of New Treatment Regimens for Multiple Myeloma: What is Right for My Patient?
Health care providers need education about how to individualize treatment plans in this complex environment to help them make the best decisions in their own practices and improve the outcomes of patients with newly diagnosed as well as those with relapsed/refractory multiple myeloma.
Category
  • Multiple Myeloma
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
Challenges and Opportunities in Marginal Zone Lymphoma: Implications of Biology on Treatment
Educating clinicians about the biology of MZLs, novel therapeutic approaches and special considerations will help them to develop an individualized treatment plan to optimize clinical outcomes.
Category
  • Non-Hodgkin's Lymphoma
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
Controversies in the Management of Early-Stage Hodgkin Lymphoma
Patients with early-stage Hodgkin lymphoma (HL) often experience high cure rates with current therapeutic measures which include chemotherapy alone or chemotherapy and radiotherapy; however, late effects due to treatment-related toxicity is of significant concern. Emerging studies are shedding light on these controversies and clinicians are challenged to remain abreast of these developments to optimize treatment of patients with early-stage HL. 
Category
  • Hodgkin Lymphoma
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
Emerging Therapeutic Options in Acute Lymphoblastic Leukemia
With increased use of immunotherapies in ALL treatment, it is important for oncology care providers to be aware of the best ways to incorporate these therapies into standard practice. Additionally, continued education will allow oncology care providers to become very conversant with the unique side effects associated with immunotherapy, leading to the development of appropriate disease management strategies.
Category
  • Acute Lymphoblastic Leukemia
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
Evolving Concepts in the Diagnosis and Staging of Multiple Myeloma
An educational program focused on the evolving concepts in diagnosis and staging of multiple myeloma (MM) is important for many reasons. The updated staging criteria represent a paradigm shift approach to MM management disease. It allows intervention before end-organ damage in selected patients who are at high risk of disease progression. The Revised International Staging System for MM allows better prediction of outcomes to tailor treatments. Advances in imaging have enabled not only early and accurate diagnosis but also provided ways of monitoring response to therapy.
Category
  • Multiple Myeloma
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
Interactive Online Case Studies: Leukemia, Myelodysplastic Syndromes, and Myeloproliferative Disorders - Case 1
Category
  • Leukemia
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
Interactive Online Case Studies: Leukemia, Myelodysplastic Syndromes, and Myeloproliferative Disorders - Case 2
Category
  • Myelodysplastic Syndrome
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation

Pages